HMGA2 and ovarian carcinoma: Therefore, based on our previous findings that indicated HMGA2 as a promising biomarker for ovarian cancer, the aim of this study has been to investigate whether cell free HMGA2 mRNA could be detected in the peripheral blood of patients with ovarian cancer.